Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT02652494
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥ 18 years of age who understand and voluntarily sign an informed consent form.
* Patients starting treatment for psoriasis with apremilast in clinical practice.
Exclusion Criteria:
* Refusal to participate in the study.
* Women who are pregnant or breast-feeding.
* Hypersensitivity to the active substance or to any of the excipients.
* Prior exposure to apremilast
* Psoriatic arthritis treated by a rheumatologist in the previous year
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02652494
Study Brief:
Protocol Section:
NCT02652494